🔓 Unlock the full profile of Xingjuan Chao (Ceribell │ Ai-Powered Point-Of-Care Eeg), including verified contact details, financial insights, and professional associations.
See Xingjuan Chao Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: xin*****@cer******.com
Mobile: 79276*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Xingjuan Chao is the Co-founder and Chief Executive Officer of Ceribell, leading the company since its inception in October 2014.
- Ceribell specializes in AI-powered point-of-care EEG technology, enhancing the diagnostics and monitoring of neurological conditions.
- Under Chao's leadership, Ceribell has achieved significant growth, reflected in a 150% increase in headcount over the past six months and over 100% growth in the last two years.
- The company's AI technology aims to streamline EEG processes, making them faster and more accessible in various healthcare settings.
- Ceribell went public, trading on NASDAQ under the symbol CBLL, achieving a market capitalization of approximately $613.3 million.
- Prior to founding Ceribell, Chao held strategic roles in prominent organizations including Genentech as a Principal Manager and Novartis as a Senior Strategy Manager.
- Chao contributes to Magnus Medical as a Board Member, further influencing advancements in medical technology.
- Chao's career started at McKinsey, where serving as an Engagement Manager provided foundational experience in strategy and management.